Vascular smooth muscle contractility assays for inflammatory and immunological mediators.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  International Immunopharmacology

• Publication date

  2010-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.intimp.2010.08.016PMID 20831918
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Successful treatment of an acute attack of acquired angioedema with the bradykinin‐B2‐receptor antagonist icatibant

  2011cited by this paper
• NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse.

  2010cited by this paper
• Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant.

  2010cited by this paper
• Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.

  2010cited by this paper
• Receptor tyrosine kinases as mediators of injury-induced bradykinin B1 receptor expression in rabbit aortic smooth muscle.

  2009cited by this paper
• Protease-activated receptors as drug targets in inflammation and pain.

  2009cited by this paper
• Effects of inactivation‐resistant agonists on the signalling, desensitization and down‐regulation of bradykinin B2 receptors

  2009cited by this paper
• Icatibant for hereditary angioedema.

  2009cited by this paper
• Receptor-independent, vacuolar ATPase-mediated cellular uptake of histamine receptor-1 ligands: possible origin of pharmacological distortions and side effects.

  2008cited by this paper
• A fluorescent version of the bradykinin B2 receptor antagonist B-9430: pharmacological characterization and use in live cell imaging.

  2008cited by this paper
• Complement activation in vascular remodeling and organ damage

  2008cited by this paper
• B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) Is an Inactivation-Resistant Agonist of the Bradykinin B2 Receptor Derived from the Peptide Antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): Pharmacologic Profile and Effective Induction of Receptor Degradation

  2007cited by this paper
• Knockout mice reveal that the angiotensin II type 1B receptor links to smooth muscle contraction.

  2007cited by this paper
• Does zaltoprofen antagonize the bradykinin receptors?

  2007cited by this paper
• Compromised aortic vasoreactivity in male estrogen receptor-alpha-deficient mice during acute lipopolysaccharide-induced inflammation.

  2007cited by this paper
• Mechanisms of Inducible Nitric Oxide Synthase–Mediated Vascular Dysfunction

  2005cited by this paper
• Endogenous Aminopeptidase N Decreases the Potency of Peptide Agonists and Antagonists of the Kinin B1 Receptors in the Rabbit Aorta

  2005cited by this paper
• Transgenic activation of the kallikrein‐kinin system inhibits intramyocardial inflammation, endothelial dysfunction, and oxidative stress in experimental diabetic cardiomyopathy

  2005cited by this paper
• Loss of function of vascular smooth muscle cells by nitric oxide‐dependent and ‐independent interactions with tumorigenic cells

  2004cited by this paper
• A non-peptide antagonist unusually selective for the human form of the bradykinin B2 receptor.

  2003cited by this paper
• Tissue Kallikrein Actions at the Rabbit Natural or Recombinant Kinin B2 Receptors

  2003cited by this paper
• Do angiotensin-converting enzyme inhibitors directly stimulate the kinin B1 receptor?

  2003cited by this paper
• Expression of kinin B1 receptor in fresh or cultured rabbit aortic smooth muscle: role of NF-κB

  2002cited by this paper
• In vitro and in vivo activity of analogues of the kinin B2 receptor antagonist MEN11270

  2002cited by this paper
• In vitro and in vivo activity of analogues of the kinin B2 receptor antagonist MEN1 1270.

  2002cited by this paper
• Expression of kinin B(1) receptor in fresh or cultured rabbit aortic smooth muscle: role of NF-kappa B.

  2002cited by this paper
• Contractile Effect of Anaphylatoxin C5a and of a Mimetic Peptide on the Human Umbilical Artery: Further Evidence for Leukocyte-Dependent Vasomotion

  2002cited by this paper
• Effects of two novel non-peptide antagonists at the rabbit bradykinin B2 receptor.

  2001cited by this paper
• A human tissue‐engineered vascular media: a new model for pharmacological studies of contractile responses

  2001cited by this paper
• Mechanisms of hydralazine induced vasodilation in rabbit aorta and pulmonary artery

  2001cited by this paper
• Antagonist-induced intracellular sequestration of rabbit bradykinin B(2) receptor.

  2000cited by this paper
• Pharmacological characterization of antagonists of the C5a receptor

  1999cited by this paper
• Pharmacological characterization of the bradykinin B2 receptor: inter‐species variability and dissociation between binding and functional responses

  1999cited by this paper
• The B1 receptors for kinins.

  1998cited by this paper
• Role of the mitogen-activated protein kinases in the expression of the kinin B1 receptors induced by tissue injury.

  1998cited by this paper
• SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

  1997cited by this paper
• FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study.

  1997cited by this paper
• Evidence for vascular tone regulation by resident or infiltrating leukocytes.

  1996cited by this paper
• Receptors for kinins in the human isolated umbilical vein

  1996cited by this paper
• Pathologic leukocyte infiltration of the rabbit aorta confers a vasomotor effect to chemotactic peptides through cyclooxygenase-derived metabolites.

  1996cited by this paper
• Mode of action of thrombin in the rabbit aorta

  1995cited by this paper
• Epidermal growth factor-induced rapid relaxation of the isolated rabbit mesenteric artery.

  1994cited by this paper
• Further analysis of the upregulation of bradykinin B1 receptors in isolated rabbit aorta by using metabolic inhibitors.

  1994cited by this paper
• Effects of peptide and nonpeptide antagonists of bradykinin B2 receptors on the venoconstrictor action of bradykinin.

  1994cited by this paper
• Rapid protein synthesis and turnover is involved in interleukin-1-induced relaxation of the rabbit isolated mesenteric artery. Analysis of the arachidonate cascade.

  1994cited by this paper
• Recombinant human hemoglobin inhibits both constitutive and cytokine-induced nitric oxide-mediated relaxation of rabbit isolated aortic rings.

  1994cited by this paper
• Aminopeptidase modulation of the pharmacological responses to synthetic thrombin receptor agonists.

  1994cited by this paper
• Pharmacological analysis of drug-receptor interaction: Kenakin, T., 2nd Edn, XII + 483 pp. New York: Raven Press (1993)

  1994cited by this paper
• Morphological and functional alterations in endothelium, smooth muscle, and nerve fibers in rabbit aorta after storage at 4 degrees C.

  1993cited by this paper
• Receptor Mechanism of Thrombin‐Induced Endothelium‐Dependent and Endothelium‐Independent Coronary Vascular Effects in Dogs

  1993cited by this paper
• Effects of thrombin and thrombin receptor activating peptides on rat aortic vascular smooth muscle.

  1993cited by this paper
• Actions of thrombin and thrombin receptor peptide analogues in gastric and aortic smooth muscle: development of bioassays for structure-activity studies.

  1992cited by this paper
• Effects of interleukin-1 receptor antagonist on three types of responses to interleukin-1 in rabbit isolated blood vessels.

  1992cited by this paper
• Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.

  1991cited by this paper
• Human interleukin‐1 induces a rapid relaxation of the rabbit isolated mesenteric artery

  1991cited by this paper
• Interleukin 1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle.

  1990cited by this paper
• Contractile effect of the chemotactic factors f-Met-Leu-Phe and C5a on the human isolated umbilical artery. Role of cyclooxygenase products and tissue macrophages.

  1990cited by this paper
• Interleukin 1 inhibits contraction of vascular smooth muscle.

  1989cited by this paper
• Pharmacological modulation of the up-regulated responses to des-Arg9-bradykinin in vivo and in vitro.

  1989cited by this paper
• Vascular endothelial cells synthesize nitric oxide from L-arginine

  1988cited by this paper
• Changes in cytosolic calcium level in vascular smooth muscle strip measured simultaneously with contraction using fluorescent calcium indicator fura 2.

  1988cited by this paper
• Distinct vascular actions of epidermal growth factor-urogastrone and transforming growth factor-alpha.

  1987cited by this paper
• Studies on the induction of pharmacological responses to des‐Arg9‐bradykinin in vitro and in vivo

  1987cited by this paper
• Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

  1987cited by this paper
• Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.

  1984cited by this paper
• Adventures and excursions in bioassay: the stepping stones to prostacylin

  1983cited by this paper
• Nobel lecture. Adventures and excursions in bioassay--the stepping stones to prostacyclin.

  1983cited by this paper
• Kininases and vascular responses to kinins.

  1982cited by this paper
• The degradation of bradykinin (BK) and of des-Arg9-BK in plasma.

  1981cited by this paper
• The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

  1980cited by this paper
• Receptors for bradykinin in rabbit aortae.

  1977cited by this paper
• Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

  1977cited by this paper
• Effects of vasoactive agents on isolated human umbilical arteries and veins.

  1972cited by this paper
• A method for the study of mechanisms of drug disposition in smooth muscle.

  1968cited by this paper

• Freestanding hydrogel lumens for modeling blood vessels and vasodilation

  2022cites this paper
• Naïve, Regulatory, Activated, and Memory Immune Cells Co-exist in PVATs That Are Comparable in Density to Non-PVAT Fats in Health

  2020cites this paper
• D-Arg0-Bradykinin-Arg-Arg, a Latent Vasoactive Bradykinin B2 Receptor Agonist Metabolically Activated by Carboxypeptidases

  2018cites this paper
• The isolated human umbilical vein as a bioassay for kinin-generating proteases: An in vitro model for therapeutic angioedema agents.

  2016cites this paper
• Infrared-emitting, peptidase-resistant fluorescent ligands of the bradykinin B2 receptor: application to cytofluorometry and imaging

  2016cites this paper
• Gastrointestinal Congestion Dilates the Hepatic Artery Through the P38 MAPK Signal Transduction Pathway During Liver Transplantation

  2016cites this paper
• Pharmacological effects of recombinant human tissue kallikrein on bradykinin B2 receptors

  2015cites this paper
• Endotoxin-Induced Monocytic Microparticles Have Contrasting Effects on Endothelial Inflammatory Responses

  2014cites this paper
• Kinin receptors in vascular biology and pathology.

  2014cites this paper
• Pharmacological evidence of bradykinin regeneration from extended sequences that behave as peptidase–activated B2 receptor agonists

  2014cites this paper
• Nouveaux ligands du récepteur B₂ de la bradykinine : endocytose dirigée et catabolisme sélectif

  2013cites this paper
• Influence of carbon nanomaterial exposure on pro-constrictor mechanisms during pregnancy

  2013cites this paper
• Vasopeptidase-activated latent ligands of the histamine receptor-1.

  2013cites this paper
• Discovery and therapeutic potential of kinin receptor antagonists

  2012cites this paper
• Met-Lys-bradykinin-Ser-Ser, a peptide produced by the neutrophil from kininogen, is metabolically activated by angiotensin converting enzyme in vascular tissue.

  2011cites this paper
• Distributed under Creative Commons Cc-by 4.0 Species-specific Pharmacology of Maximakinin, an Amphibian Homologue of Bradykinin: Putative Prodrug Activity at the Human B 2 Receptor and Peptidase Resistance in Rats

  year unknowncites this paper